On Monday, Shares of King Digital Entertainment PLC (NYSE:KING), lost -3.12% to $14.60.
King Digital Entertainment, reported financial results for the first quarter ended March 31, 2015.
King CEO Riccardo Zacconi said, “Our first quarter 2015 results demonstrate the continued strength of our franchises, with Candy Crush Saga, Candy Crush Soda Saga and Farm Heroes Saga remaining top 10 grossing games in the Apple App Store and Google Play Store in the U.S. We are pleased by the sustained popularity of our games which is also reflected in our second consecutive quarter of company-high network reach metrics and we look forward to leveraging the extraordinary power of our massive player base in launching new innovative games in 2015 and beyond.”
King Digital Entertainment plc, an interactive entertainment company, produces and distributes digital games on multiple platforms in the United States, the United Kingdom, Germany, and internationally.
Shares of Juniper Networks, Inc.(NYSE:JNPR), inclined 1.10% to $27.62, during its last trading session.
Juniper Networks, Inc., released details regarding its upcoming participation at the OpenStack Summit Vancouver, an annual conference for developers, users, and administrators of OpenStack Cloud Software.
At the conference, Juniper will participate in multiple sessions including discussions on hybrid clouds, network functions virtualization (NFV) and multi-tenant clouds for software as-a-service (SaaS) applications. Additionally, Juniper will have a demo table located in the sponsor exhibit hall in booth T3, as well as Contrail demos in partner booths, including the Ubuntu supported by Canonical booth P3 and Mirantis booth P7. Adding to the content onsite at the show, Juniper will also host an OpenContrail user group meeting at the Pan Pacific Vancouver Hotel.
Juniper Networks, Inc. designs, develops, and sells high-performance network products and services worldwide. It provides various routing products, including ACX series universal access routers to deploy new high-bandwidth services; MX series Ethernet routers that functions as a universal edge platform; M series edge routers; PTX series packet transport routers; and T series routers.
At the end of Monday’s trade, Shares of Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), gained 3.29% to $4.39.
Arena Pharmaceuticals, Inc, declared that lorcaserin HCl data will be presented at the following medical meetings:
American Thoracic Society International Conference taking place in Denver, Colorado, May 15-20, 2015.
Lorcaserin for Smoking Cessation Treatment in Cigarette Smokers: A Randomized Phase 2 Trial, Poster Number: 118.
This study evaluated the efficacy of lorcaserin 10 mg twice daily for smoking cessation and body weight change in a population of dependent smokers over placebo.
International Society for Pharmacoeconomics and Outcomes Research taking place in Philadelphia, Pennsylvania, May 16-20, 2015.
Cost Implication of Using Lorcaserin in Weight Management Prior to Bariatric Surgery. Poster Number: PSY21.
This study evaluated the cost implication of using lorcaserin for weight loss prior to bariatric surgery over a two-year horizon from the payer’s perspective.
Lorcaserin is an investigational product for smoking cessation. The efficacy and safety of lorcaserin for smoking cessation have not been established.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. It is also developing a portfolio of programs in various therapeutic areas, including cardiovascular, central nervous system, and metabolic diseases.
Finally, Select Medical Holdings Corporation (NYSE:SEM), ended its last trade with 3.06% gain, and closed at $15.50.
Select Medical Holdings Corporation, declared results for its first quarter ended March 31, 2015.
For the quarter ended March 31, 2015, net operating revenues increased 4.3% to $795.3 million, compared to $762.6 million for the same quarter, prior year. Income from operations was $79.3 million for the quarter ended March 31, 2015, compared to $78.4 million for the same quarter, prior year. Net income attributable to Select Medical was $35.1 million for the quarter ended March 31, 2015, compared to $33.0 million for the same quarter, prior year. Net income attributable to Select Medical for the quarter ended March 31, 2014 includes a loss on early retirement of debt, net of tax, of $1.4 million. Net income before interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, equity in earnings (losses) of unconsolidated subsidiaries and other income (expense) for the quarter ended March 31, 2015 increased 2.2% to $98.9 million, compared to $96.8 million for the same quarter, prior year. A reconciliation of net income to Adjusted EBITDA is presented in table V of this release. Income per common share for the quarter ended March 31, 2015 was $0.27 on a fully diluted basis compared to income per common share of $0.24 for the same quarter, prior year. Excluding the loss related to the early retirement of debt and the related tax effect, adjusted income per common share was $0.25 per diluted share for the quarter ended March 31, 2014. There was no loss related to the early retirement of debt during the quarter ended March 31, 2015. A reconciliation of net income per common share to adjusted income per common share for the quarter ended March 31, 2014 is presented in table VI of this release.
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates specialty hospitals and outpatient rehabilitation clinics in the United States. It operates in two segments, Specialty Hospitals and Outpatient Rehabilitation. The Specialty Hospitals segment provides long term acute care hospital services and inpatient acute rehabilitative hospital care.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
